Status and phase
Conditions
Treatments
About
The purpose of this prospective trial is to demonstrate the safety and performance of the Second Generation Anti-Microbial vascular graft in the treatment of aneurysmal and occlusive diseases of the abdominal aorta.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
60 participants in 1 patient group
Loading...
Central trial contact
Philippe Bensimon, Director; Jean-Baptiste Ricco, MD, Professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal